Abridge
AI ambient scribe that turns live clinical conversations into accurate notes — trusted by 300+ health systems.
Overview
Abridge is an enterprise-grade generative AI platform that listens to physician-patient conversations in real time and automatically produces structured clinical notes, after-visit summaries, and revenue-cycle-ready documentation. Founded in 2018 by cardiologist Dr. Shivdev Rao and built out of Carnegie Mellon University, the platform supports 55+ medical specialties, 28+ languages, and integrates natively into Epic as a Premier Partner. It has been deployed at Kaiser Permanente (40 hospitals, 24,600 physicians), Mayo Clinic, Duke Health, Johns Hopkins Medicine, and over 300 health systems, processing more than 100 million clinical conversations annually as of 2026.
Beyond ambient documentation, Abridge's Contextual Reasoning Engine extends into nursing workflows, ICD-10/HCC medical coding, prior-authorization assistance (via an Availity partnership), and evidence-linked clinical decision support co-developed with NEJM and JAMA. Peer-reviewed research in NEJM AI (1,306 clinicians) scored note quality at 4.35/5, and a KUMC study found a 61% reduction in cognitive load. The platform holds HIPAA, SOC 2 Type II, and ISO 27001 certifications, with all data stored and processed in US-based data centres. Abridge earned Best in KLAS for Ambient AI in both 2025 and 2026 — the only vendor to hold the title consecutively.
Pricing
Pricing shown for reference only. These figures reflect RECATOOLS research as of 16 Jun 2026 and may be out of date or incomplete. This is not financial or purchasing advice — always confirm the current price on the provider’s official website before making any decision.
Use cases
What you can produce with Abridge
- Structured clinical note (SOAP or specialty-specific format) generated from a live physician-patient encounter
- Patient after-visit summary in plain, accessible language ready to share at discharge
- ICD-10 / HCC-coded billing documentation extracted automatically from the encounter transcript
- Linked transcript with audio timestamps so every note assertion traces back to the spoken source
- Nursing encounter-to-documentation conversion for inpatient and ambulatory nursing workflows
- Prior-authorization support document with evidence citations drawn from the clinical conversation
- Ambient encounter summary integrated directly into the Epic chart via the Abridge-Epic native connection
ASEAN Perspective
Abridge in Southeast Asia
Abridge is currently a US-market product with no announced APAC presence, no regional data centres, and no known partnerships with hospitals in Southeast Asia, Australia, or the broader APAC region as of mid-2026. All audio and clinical data is processed in US-based servers, creating significant data-sovereignty and patient-consent obstacles under Singapore's PDPA, Malaysia's PDPA, Thailand's PDPC Act, and Australia's Privacy Act — making enterprise adoption by ASEAN health systems legally complex without contractual data-residency guarantees. The platform's 28+ language support theoretically covers Malay, Indonesian, Thai, and Tagalog, but clinical accuracy in these languages has not been independently validated, and there is no Epic footprint in most ASEAN public health systems. ASEAN healthcare providers should treat Abridge as a future-watch product rather than a deployable solution in the near term.
Abridge is the clear market leader in ambient AI documentation for large US health systems, validated by more peer-reviewed research than any competitor, Best in KLAS two consecutive years, and deployments at the most prestigious names in American medicine. Its native Epic embedding, 28+ language support, and evidence-linked note traceability set a quality bar that most rivals have not matched. For organisations already on Epic and able to navigate an enterprise procurement cycle, it is arguably the safest, most clinically credible choice available in 2026.
The caveats are real, however. Abridge is enterprise-only — individual clinicians, small practices, and systems on non-Epic EHRs face significant friction or outright unavailability. Pricing of roughly $2,500 per clinician annually (possibly higher with deeper integrations) is 40–60% above some comparable ambient scribes. All data is processed in US data centres with no confirmed APAC or EU residency options, which creates compliance barriers for healthcare providers outside North America. There is no public API, no self-serve trial, and limited configurability for specialties or workflows not already templated. For health systems weighing cost or operating outside the US, the value equation requires careful scrutiny.
What people say
Abridge earns a G2 rating of 4.7/5 from verified users and was ranked #1 Best in KLAS for Ambient Speech (2025) and top-ranked again in 2026 for Ambient AI in Revenue Cycle Management. Clinician feedback highlights reduced documentation burden — peer-reviewed studies report meaningful reductions in documentation time and after-hours charting — plus strong Epic integration and note accuracy backed by validation. The main criticism is access: enterprise-only contracting with no self-serve option, premium pricing, and US-centric data infrastructure that limits global usability. For large Epic-based health systems, it is widely regarded as best-in-class.
Summary of public user & expert reviews, compiled by RECATOOLS.
Notable facts
- Abridge was born from the Pittsburgh Health Data Alliance — a three-way partnership between Carnegie Mellon University, the University of Pittsburgh, and UPMC.
- Kaiser Permanente's Abridge rollout across 40 hospitals and 600 clinics is considered the largest generative AI project in healthcare history.
- Abridge's valuation nearly doubled in just four months in 2025 — from $2.75B (February) to $5.3B (June) — on the back of a $300M Series E led by Andreessen Horowitz.
- A KUMC peer-reviewed study found Abridge reduced clinician cognitive load by 61%, and at Sutter Health 78% of clinicians reported improved work satisfaction.
Frequently asked questions
About this listing
This entry was compiled from publicly available data including Abridge's official website, press releases, documentation, and reputable third-party publications. RECATOOLS is not affiliated with Abridge unless explicitly stated.
Third-party AI tools update their pricing, features, availability, and policies frequently. Information here may be outdated by the time you read this — we make reasonable efforts to keep listings current, but cannot guarantee absolute accuracy.
For the latest details, please refer to Abridge directly →
Spotted something out of date? Suggest an update →
More in Other
